AG
TBIO

Aperio Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Aperio Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$335K Buy
18,194
+6,723
+59% +$120K ﹤0.01% 2131
2020
Q3 		$156K Sell
11,471
-380
-3% -$5.86K ﹤0.01% 2266
2020
Q2 		$212K Buy
11,851
+1,764
+17% +$26.6K ﹤0.01% 2160
2020
Q1 		$101K Buy
+10,087
New +$82.6K ﹤0.01% 2216

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aperio Group's TBIO Position: Q4 2020 in Review

Aperio Group increased its Translate Bio, Inc. Common Stock (TBIO) stake by 59% in Q4 2020, buying an estimated $120K and bringing the position to 18,194 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Aperio Group first reported a position in TBIO in Q1 2020 and has held it in 4 quarters since. 150 funds tracked by Wall St. Rank hold TBIO as of Q4 2020.

  • Aperio Group held 18,194 shares of Translate Bio, Inc. Common Stock worth $335K as of Q4 2020.
  • Aperio Group bought 6,723 Translate Bio, Inc. Common Stock shares in Q4 2020, an estimated $120K.
  • Translate Bio, Inc. Common Stock made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2131 holding.
  • Aperio Group first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and has held it in 4 quarters since.
  • 150 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.